Gillmore, JD;    Maitland, ML;    Lebwohl, D;      (2021)    CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.                   New England Journal of Medicine , 385    pp. 1722-1723.    10.1056/NEJMc2114592 <https://doi.org/10.1056/NEJMc2114592>.       Green open access